Skip navigation
MedlinePlus Trusted Health Information for You U.S. National Library of MedicineNational Institutes of Health
Contact Us FAQs Site Map About MedlinePlus
español Home Health Topics Drugs & Supplements Medical Encyclopedia Dictionary News Directories Other Resources

 

Medical Encyclopedia

Other encyclopedia topics:  A-Ag  Ah-Ap  Aq-Az  B-Bk  Bl-Bz  C-Cg  Ch-Co  Cp-Cz  D-Di  Dj-Dz  E-Ep  Eq-Ez  F  G  H-Hf  Hg-Hz  I-In  Io-Iz  J  K  L-Ln  Lo-Lz  M-Mf  Mg-Mz  N  O  P-Pl  Pm-Pz  Q  R  S-Sh  Si-Sp  Sq-Sz  T-Tn  To-Tz  U  V  W  X  Y  Z  0-9 

Spinal muscular atrophy

Printer-friendly versionEmail this page to a friend
Contents of this page:

Illustrations

Superficial anterior muscles
Superficial anterior muscles

Alternative Names    Return to top

Werdnig-Hoffmann disease

Definition    Return to top

Spinal muscular atrophy is a group of inherited diseases that cause progressive muscle degeneration and weakness, eventually leading to death.

Causes    Return to top

Spinal muscular atrophy (SMA) is the second leading cause of neuromuscular disease. It is inherited as an autosomal recessive trait (a person must get the defective gene from both parents to be affected) and has an incidence of approximately 4 per 100,000 people.

In its most severe form (SMA type I, also called Werdnig-Hoffman disease), infants are born floppy with weak, thin muscles and feeding and breathing problems. Their lifespan seldom exceeds 2 to 3 years. Infants with SMA type II have less severe symptoms during early infancy, but they become progressively weaker with time. Survival time with type II is longer, but the disease kills most of those affected while they are still children.

SMA type III is the least severe form of the disease, and symptoms may not appear until the second year of life. Often, weakness is first noted in the shoulder muscles and proximal leg muscles. Weakness is progressive and will eventually become profound, but children with type III disease may survive into early adulthood.

Rarely, SMA may begin in adulthood. This is usually a milder form of the disease. This form may be inherited in an autosomal dominant (only one copy of the gene is needed for the disease to occur) or autosomal recessive manner.

Family history of spinal muscular atrophy is a risk factor for all types of the disorder.

Symptoms    Return to top

In an infant:

In a child:

Exams and Tests    Return to top

Tests:

Treatment    Return to top

There is no treatment for the progressive weakness caused by the disease. Supportive care is important. Attention must be paid to the respiratory system, because affected people have difficulty clearing secretions. Respiratory complications are common.

Physiotherapy is important to prevent contractures and scoliosis. Bracing may be necessary.

Outlook (Prognosis)    Return to top

The most severe form of spinal muscular atrophy is fatal early on. The less severe form is compatible with a longer lifespan. However, progressive weakness and debility are present in all forms.

Possible Complications    Return to top

When to Contact a Medical Professional    Return to top

Call your health care provider if your child appears weak, has difficulty feeding, or develops any other symptoms of spinal muscular atrophy. Breathing difficulty can rapidly become an emergency condition.

Prevention    Return to top

Genetic counseling is recommended for prospective parents with a family history of spinal muscular atrophy.

Update Date: 9/10/2006

Updated by: Daniel Kantor, M.D., Director of the Comprehensive MS Center, Neuroscience Institute, University of Florida Health Science Center, Jacksonville, FL. Review provided by VeriMed Healthcare Network.

A.D.A.M. Logo

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 1997-2009, A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.